Umer Raffat analyst EVERCORE

Currently out of the existing stock ratings of Umer Raffat, 10 are a BUY (76.92%), 1 are a SELL (7.69%), 2 are a HOLD (15.38%).

Umer Raffat

Work Performance Price Targets & Ratings Chart

Analyst Umer Raffat works at EVERCORE with a stock forecast success ratio of 16.67% fulfilled within 21.67 days on average.

Umer Raffat’s has documented 21 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ALKS, Alkermes Plc at 24-Oct-2023.

Wall Street Analyst Umer Raffat

Analyst best performing recommendations are on ALKS (ALKERMES PLC).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 6/9/2016. The price target of $59 was fulfilled within 154 days with a profit of $15.18 (34.64%) receiving and performance score of 2.25.

Average potential price target upside

OGN Organon AMLX Amylyx Pharmaceuticals ALKS Alkermes Plc CELG Celgene MYL Viatris PHAT Phathom Pharmaceuticals VTRS Viatris AGN Allergan plc AMGN Amgen MDCO The Medicines Company GILD Gilead Sciences RPRX Royalty Pharma Plc TEVA Teva Pharma Industries Ltd ADR CERE Cerevel Therapeutics Holdings

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

18

$-0.16 (-0.88%)

16

1 months 24 days ago

2/3 (66.67%)

$-0.21 (-1.15%)

36

Buy

22

$3.84 (21.15%)

32

4 months 22 days ago

1/4 (25%)

$10.93 (98.74%)

146

Hold

22

$3.84 (21.15%)

27

6 months 2 days ago

4/8 (50%)

$5.46 (33.01%)

109

Hold

8 months 13 days ago

0/1 (0%)

$8.93 (30.72%)

Buy

33

$15.64 (90.09%)

1 years 28 days ago

0/1 (0%)

$11.28 (51.93%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Umer Raffat is most bullish on?

Potential upside of $0 has been obtained for ALKS (ALKERMES PLC)

What Year was the first public recommendation made by Umer Raffat?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?